Thomas Baumert received his MD from the University of Heidelberg, Germany. Following his doctoral thesis at the German Cancer Research Center (DKFZ) in Heidelberg, Germany (head: Nobel laureate Prof. H. zur Hausen) and his internship in Internal Medicine at the Ludwig Maximilians University in Munich, Germany he was a post-doctoral fellow in Dr. T.J. Liang’s laboratory in the Dept. of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, and the Liver Diseases Branch at the National Institutes of Health, Bethesda, USA.
He then went on to join the Department of Medicine at the University Hospital of Freiburg, Germany where he became a board-certified internist and gastroenterologist and established his laboratory focusing on the molecular pathogenesis of hepatitis B and C virus infection. He was awarded an associate professorship in 2002. In 2006, he relocated to the University of Strasbourg, France as a full Professor of Medicine to create and head a new Inserm research unit focussing on virus-host interactions and disease biology and establish a highly competitive program in virology and hepatology.
He has received several awards including the Hans Popper Young Investigator Award, the Chair of Excellence Award of the French National Research Agency and the Infectious Disease Award of the German Infectious Disease Society. Most recently he was awarded the Prix Galien for the discovery of host-targeting entry inhibitors as a novel strategy for prevention and treatment of HCV infection. He has published more than 250 scientific articles and is an inventor on 15 patents and patent applications.